Urine testing remains a fundamental part of modern diagnostics, helping healthcare professionals assess kidney function, identify urinary tract infections, and detect signs of conditions such as diabetes and liver disease. As healthcare providers place greater emphasis on early diagnosis and preventive screening, the Urinalysis Market is benefiting from continued demand for diagnostic consumables, laboratory instruments, and automated testing solutions.

Market Size and Key Statistics

• 2024 market value: USD 4.4 billion

• 2026 estimated market value: USD 5.1 billion

• 2030 projected market value: USD 6.9 billion

• Projected CAGR: 7.8% from 2025 to 2030

• Largest regional market: North America, with a 37.9% revenue share in 2024

• Fastest-growing regional market: Asia Pacific 

Download a free sample copy of the Urinalysis Market report to understand detailed coverage and inclusions in the final report

Why Demand for Urinalysis Is Increasing

Urinalysis is widely used because it provides valuable clinical information through a relatively accessible diagnostic procedure. A urine sample can be examined for substances such as glucose, protein, blood, ketones, and other indicators that may help healthcare professionals determine whether additional testing is necessary.

The increasing burden of urinary tract infections, diabetes, and kidney disorders is strengthening demand for routine testing. Urinalysis can support the initial assessment of these conditions, although additional diagnostic procedures may be required to confirm a diagnosis.

An ageing population is another factor influencing market development. Older adults are more likely to experience multiple chronic conditions and may require regular diagnostic monitoring. Hospitals and laboratories therefore need dependable testing systems that can process samples efficiently while delivering consistent results.

Automation Is Changing Laboratory Workflows

Laboratory automation is an important trend reshaping the urinalysis industry. Traditional manual testing and microscopy can require substantial staff time, particularly when laboratories process large numbers of samples. Automated analyzers help standardize routine procedures and improve laboratory productivity.

Modern instruments can combine chemical analysis with urine particle examination, allowing laboratories to identify abnormalities more efficiently. Automated systems may also reduce repetitive manual tasks, support consistent reporting, and help laboratories manage increasing testing volumes.

The instruments segment is expected to grow at the fastest CAGR from 2025 to 2030, according to Grand View Research. This trend reflects continued interest in advanced analyzers, improved diagnostic capabilities, and laboratory modernization.

Manufacturers are also developing compact and user-friendly systems for smaller laboratories and point-of-care settings. As diagnostic providers seek to balance accuracy, speed, and operating costs, automation is likely to remain a significant source of market opportunity.

Consumables Account for the Largest Product Share

Consumables form the backbone of routine urinalysis because they are needed repeatedly for everyday testing. This category includes reagent strips, dipsticks, chemical reagents, sample collection products, and other disposable supplies.

Grand View Research reports that consumables accounted for 78.6% of total market revenue in 2024. Frequent replenishment requirements and widespread use across clinical laboratories and hospitals help explain the segment's substantial contribution.

Reagent strips are particularly useful for preliminary screening because they can detect several chemical indicators in urine. Depending on the test and clinical situation, abnormal results may lead to further laboratory investigation.

Although consumables currently dominate the market, instruments remain important to long-term industry development. Automated analyzers, digital imaging systems, and advanced urine particle analysis technologies offer opportunities for manufacturers serving laboratories with increasing testing requirements.

UTI Screening Remains a Major Application

Urinary tract infection screening represented 24.07% of the Urinalysis Market revenue in 2024, making it the leading application. UTIs are common infections, and urine testing plays an important role in evaluating patients with symptoms suggestive of urinary infection.

Urinalysis may identify indicators such as leukocytes, nitrites, and blood. Depending on symptoms and clinical findings, healthcare professionals may also request urine culture testing to help identify the responsible microorganism and guide treatment.

Other applications include diabetes screening, kidney disease assessment, hypertension-related monitoring, and the investigation of certain liver conditions. Urine testing can help detect glucose or protein abnormalities, among other findings, supporting decisions about further evaluation.

The growing focus on early identification of chronic diseases is creating additional demand for diagnostic tests. Grand View Research identifies diabetes screening as the fastest-growing application segment, with a projected CAGR of 10.6% during the forecast period. 

Go Deeper! Ask Prism AI

about the Global Urinalysis Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Clinical Laboratories and Home Testing Expand Access

Clinical laboratories accounted for approximately 45.88% of market revenue in 2024. Their established role in diagnostic testing, access to specialized equipment, and ability to process large sample volumes contribute to their market position.

Hospitals also remain important users of urinalysis solutions, particularly for emergency assessments, inpatient care, and routine diagnostic investigations. The need for timely results encourages healthcare facilities to invest in reliable analyzers and testing supplies.

Home-based testing products may appeal to consumers seeking convenience and preliminary screening, although not all tests are suitable for self-diagnosis. Abnormal findings should be discussed with an appropriate healthcare professional.

Regional Outlook

North America accounted for 37.9% of the global Urinalysis Market revenue in 2024. The United States is a major contributor, with hospitals and clinical laboratories investing in diagnostic technologies to support growing testing requirements. Product innovation and partnerships between diagnostic technology providers and laboratory software companies are also influencing the market.

Asia Pacific, meanwhile, is identified as the fastest-growing regional market. Expanding healthcare infrastructure, increasing access to diagnostic services, and greater awareness of chronic disease screening are creating opportunities for industry participants.

Looking for more specific insights? Customize this report to suite your business needs

Competitive Landscape and Future Opportunities

The industry includes established diagnostics companies such:

• Abbott

• Sysmex Corporation

• Siemens Healthineers AG

• ACON Laboratories, Inc.

• ARKRAY Inc.

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• F. Hoffmann-La Roche Ltd.

• Quidel Corporation

• Bio-Rad Laboratories, Inc.

Competition increasingly involves more than the sale of individual instruments. Manufacturers are developing integrated testing systems, improving ease of use, expanding consumables portfolios, and supporting laboratories with software and workflow solutions.

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Explore U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database